HighTower Advisors LLC Raises Holdings in GE HealthCare Technologies Inc. $GEHC

HighTower Advisors LLC increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 50.5% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 590,842 shares of the company’s stock after buying an additional 198,168 shares during the period. HighTower Advisors LLC’s holdings in GE HealthCare Technologies were worth $48,461,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in GEHC. Empowered Funds LLC raised its position in shares of GE HealthCare Technologies by 6.1% in the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after buying an additional 1,665 shares during the period. Acadian Asset Management LLC purchased a new position in GE HealthCare Technologies in the first quarter valued at about $259,000. Cresset Asset Management LLC raised its position in GE HealthCare Technologies by 12.5% in the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock valued at $578,000 after purchasing an additional 865 shares during the period. Jump Financial LLC raised its position in GE HealthCare Technologies by 317.6% in the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after purchasing an additional 21,396 shares during the period. Finally, Gamco Investors INC. ET AL raised its position in GE HealthCare Technologies by 8.6% in the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after purchasing an additional 320 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

GEHC has been the topic of several research reports. Jefferies Financial Group cut their price objective on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Mizuho cut their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Oppenheimer reissued an “outperform” rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Argus cut their price objective on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, Barclays cut their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 30th. Nine equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $80.21.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Peter J. Arduini bought 4,169 shares of the stock in a transaction dated Thursday, April 30th. The stock was bought at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the purchase, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO James Saccaro purchased 3,310 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the purchase, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This represents a 3.93% increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders acquired 11,847 shares of company stock valued at $719,555. 0.36% of the stock is currently owned by insiders.

GE HealthCare Technologies Stock Up 0.1%

Shares of GE HealthCare Technologies stock opened at $64.33 on Friday. The business has a 50-day moving average of $68.62 and a 200-day moving average of $76.33. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The company has a market capitalization of $29.26 billion, a PE ratio of 15.39, a P/E/G ratio of 1.45 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.